Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUT vs GSK✓SelectedUSD · GSKHUT vs GSK performance historyLatest closeAs of-7.54%11/16
Stock and ETF performance explorer

HUT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.1%
GSK return
+47.4%
Excess return
-68.4%
Maximum drawdown
-94.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.5%-0.1%-7.5%-7.5%
7D-6.6%-1.3%-5.3%-6.7%
30D-21.4%+2.7%-24.2%-21.4%
3M-37.7%+2.7%-40.4%-37.7%
6M-48.1%+3.3%-51.4%-48.4%
YTD+15.9%+6.5%+9.4%+15.0%
1Y+44.1%+10.7%+33.4%+42.1%
3Y+472.4%+64.4%+408.0%+357.1%
All-21.1%+47.4%-68.4%-48.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling